RAES 17th UK Regenerative Aesthetic ExoCoBio Summit 2025

Celebrating the future of Regenerative Aesthetics with Cure Medical and ExoCoBio

With exosome-based treatments gaining rapid momentum in global aesthetics, Cure Medical and ExoCoBio joined forces this June to lead the conversation on next-generation regenerative technologies.

Over two days, the RAES 17th UK Regenerative Aesthetic ExoCoBio Summit 2025, held at the Royal Society of Medicine and Nobu Hotel, showcased the latest clinical insights, innovations,

and practical approaches driving this fast-evolving field. The event brought together leading practitioners, researchers and industry partners, highlighting the growing role of exosomes in non-surgical skin and hair restoration, wound healing, and cellular regeneration.

Day One: 16 June at the Royal Society of Medicine

The summit’s scientific programme featured a series of high-level presentations, offering new evidence and perspectives:

• Ms Sabrina Shah Desai: “Skin Rejuvenation with Exosomes: From the Lab to the Clinic”
• Dr Mehmet Cimen: “From Hair Loss to Hair Regrowth: Rose Stem Cell Derived Exosomes as a Game Changer in Alopecia”
• Professor Jan Lötvall: “The Concept, Clinical Translation and Safety of Exosomes”
• Dr Juliah Tbarani: “ASCE Plus Exosomes:
• A Regenerative Breakthrough in the Treatment of Diverse Alopecia Subtypes”
• Mr Byong Cho, CEO of ExoCoBio: “ASCEPlus Exosomes: Deciphering Proteins, miRNAs and Lipids for Targeted Regeneration”
• Dr Elina: “Maximising Quality and Safety
• in Aesthetic Treatments with Exosomes”

A Q&A followed, providing a forum for important conversation on clinical implementation, regulatory trends, and patient outcomes. The summit also facilitated valuable peer-to-peer exchanges among UK and international experts in regenerative and aesthetic medicine.

“It was an absolute pleasure to bring the 17th UK Regenerative Aesthetic Exosome Summit to life again. It’s exciting to see exosomes moving from theory into everyday clinical practice, and we’re proud to be working with ExoCoBio, whose innovation is helping set new standards in this field. Our goal at Cure Medical is to make sure clinics here in the UK can access the very best regenerative technologies. With events like this showing how far the industry has come, and where it’s heading next.”

— Adam Bashir, CEO of Cure Medical

Day Two: 17 June at Nobu Portman Square

Day two concluded with a VIP industry dinner hosted by Adam Bashir and Mr Byong Cho at Nobu Hotel and Restaurant. The evening offered an opportunity to recognise the progress being made in regenerative aesthetics, and to strengthen collaboration between clinical, scientific and industry leaders.

With interest in exosome-based therapies expanding across the global aesthetics market, Cure Medical and ExoCoBio remain committed to delivering clinically proven, next-generation solutions that elevate standards of care and advance transformational outcomes for patients.